Select Page


Discover, Control & Prevent diabetic risk.

How does MDDiabeticPro differ from other diabetes tests?

PMLS offers a variety of biomarkers on our diabetes test panel. Besides running a normal A1C test, PMLS goes further and tests a patient’s Fasting Glucose, GlycoMark, Adiponectin, Leptin, HOMA-IR, Insulin, and C-peptide, but we don’t stop there. To give patient’s a look at the bigger picture, we also run a Comorbidity Assessment of Cardiovascular and Renal biomarkers, as well as a Genetic Predisposition test called DIABETESpredict™.  With DIABETESpredict™, doctors can help their patients know their risk for type 2 diabetes earlier.

MdDiabeticPro is also specifically designed to help Type 1 diabetes patients with the management of the disease. This test can be used for monitoring individuals who are pre-disposed to insulin resistance. The results of the test equip physicians with the information needed to fine tune nutrition and exercise plans, helping a T1D patient to make the use of insulin most effective.

    Know your risk with DIABETESPredict™

    DIABETESpredict™ is a genotyping tool for type 2 diabetes risk assessment. It analyzes the main genetic variants associated with T2D, taking into account multi-ethnic associations. DIABETESpredict™ identifies high risk individuals and gives them additional information to implement lifestyle changes. Early identification of type 2 diabetes enables prevention and with DIABETESpredict™ doctors are empowered to help their patients further.

      More than
      500 Million worldwide suffer
      type-2 diabetes.
      In 2018,
      34.2 Million Americans, or 10.5% of the population, had diabetes.

      Let’s Talk

      We want to hear from you! Tell us more about your interest in MDChemistryPro today.

      Read Our Blog

      Breast Cancer Awareness Month

      Breast Cancer Awareness Month

      Breast cancer is the second most common cancer among women in the U.S. This year, an estimated 290,000 new cases of invasive breast cancer will be diagnosed in women. Although this is an alarming number, breast cancer is a highly treatable disease, and early detection...

      read more